Intellia Therapeutics Inc (NTLA) financials · rev $67.7M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Intellia Therapeutics Inc (NTLA) rev $67.7M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $67.7M | $57.9M |
| Operating Income | -$441.0M | -$534.3M |
| Net Income | -$412.7M | -$519.0M |
| EPS (Diluted) | -$3.81 | -$5.25 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $842.1M | $1.19B |
| Current Assets | $527.7M | $639.9M |
| Cash & Equivalents | $155.5M | $189.2M |
| PP&E | $17.7M | $27.4M |
| Total Liabilities | $170.7M | $319.1M |
| Current Liabilities | $103.9M | $110.9M |
| Shareholders' Equity | $671.4M | $872.0M |
| Retained Earnings | -$2.59B | -$2.18B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$394.7M | -$348.9M |
| CapEx | $1.13M | $5.78M |
| Investing Cash Flow | $228.0M | $125.6M |
| Financing Cash Flow | $131.5M | $185.7M |
| Net Change in Cash | -$35.2M | -$37.6M |
| Free Cash Flow | -$395.9M | -$354.7M |
FAQ
What is NTLA P/E and revenue?
Intellia Therapeutics Inc (NTLA) rev $67.7M.
What is NTLA revenue?
Intellia Therapeutics Inc last cached revenue is $67.7M (FY2025).
Is NTLA profitable?
Intellia Therapeutics Inc last cached net income is -$412.7M (FY2025).
What are NTLA total assets?
Intellia Therapeutics Inc last cached total assets are $842.1M (FY2025).
What is NTLA free cash flow?
Intellia Therapeutics Inc last cached free cash flow is -$395.9M (FY2025).
Not investment advice. Cached statements, not a live tape.